tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Karuna Therapeutics reports Q4 EPS ($2.22), consensus ($2.25)

Reports Q4 revenue $5,278, consensus $10,000. $1.1B in cash is expected to fund operations through the end of 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on KRTX:

Disclaimer & DisclosureReport an Issue

1